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Neurons share many features in common but are distinguished by expression of phenotypic characteristics that define their specific
function, location, or connectivity. One aspect of neuronal fate determination that has been extensively studied is that of neurotransmitter
choice. The generation of diversity of neuronal subtypes within the developing nervous system involves integration of extrinsic and intrinsic
instructive cues resulting in the expression of a core set of regulatory molecules. This review focuses on mechanisms of growth and
transcription factor regulation in the generation of peripheral neural crest-derived neurons. Although the specification and differentiation of
noradrenergic neurons are the focus, I have tried to integrate these into a larger picture providing a general roadmap for development of
autonomic neurons. There is a core of DNA binding proteins required for the development of sympathetic, parasympathetic, and enteric
neurons, including Phox2 and MASH1, whose specificity is regulated by the recruitment of additional transcriptional regulators in a subtype-
specific manner. For noradrenergic neurons, the basic helix-loop-helix DNA binding protein HAND2 (dHAND) appears to serve this
function. The studies reviewed here support the notion that neurotransmitter identity is closely linked to other aspects of neurogenesis and
reveal a molecular mechanism to coordinate expression of pan-neuronal genes with cell type-specific genes.
D 2004 Elsevier Inc. All rights reserved.
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A challenge in developmental neurobiology is to
delineate the molecular mechanisms governing diversifica-
tion of neuronal phenotypes developing from multipotent
progenitor cells. In the vertebrate nervous system, two broad
classes of neuronal progenitor cells have been identified;
multipotent cells resident within the ventricular zone and
neural crest-derived cells. Neuronal elements (neurons,
astrocytes, oligodendrocytes) in the central nervous system
are derived from the cells in the ventricular zone while
peripheral neurons and schwann/glial cells are derived from
the neural crest. Although progenitor cells giving rise to
central and peripheral neurons themselves have a different
developmental history, differentiation of these cells into0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: mhoward@mco.edu.neurons appears to follow a general pattern. Proneural
genes, members of the basic helix-loop-helix (bHLH)
family of transcription factors, initially select progenitor
cells previously specified to a neuronal fate. In a series of
subsequent steps, the activity of proneural genes, either
alone or in concert with additional bneuronal differentiationQ
genes, activates the NOTCH signaling pathway, cell cycle
withdrawal, and pan-neuronal and cell type-specific gene
expression (for review, see Bertrand et al., 2002; Briscoe
and Ericson, 2001; Jessell, 2000). How the expression of
pan-neuronal characteristics is coordinated with cell type-
specific gene expression remains a central question for both
central and peripheral neurons. Identification and character-
ization of choice points in the process of specification and
differentiation of neurons are exemplified in neural crest-
derived noradrenergic sympathetic ganglion neurons. Sym-
pathetic ganglion neurons have provided an excellent
system in which to assess the contribution of both genetic
and epigenetic interactions required for the differentiation of
this cell type. This review will focus on growth and277 (2005) 271–286
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eral neurons, emphasizing the differentiation of sympathetic
noradrenergic neurons.Extrinsic signals
To understand fully how neuronal diversity is gener-
ated begs the question of how neural progenitors become
fate restricted in the appropriate location; this is a
particularly compelling issue for neural crest-derived
neurons as the majority differentiate at a great distance
from their site of origin on the dorsal neural tube. Several
extrinsic signals providing instructive cues for fate
determination of neural crest-derived neural progenitors
have been identified (Hagedorn et al., 2000; Hari et al.,
2002; Lee et al., 2004; Morrison et al., 2000; Paratore et
al., 2002; Schneider et al., 1999; Shah et al., 1996). The
most prominent of these factors are bone morphogenetic
proteins (BMPs) (Schneider et al., 1999) and Wnt (Hari et
al., 2002; Lee et al., 2004). Defining the exact timing
when neural crest-derived cells become fate restricted to a
particular neuronal lineage is controversial, but it is clear
that multipotent progenitor cells are resident in many
neural crest-derived structures (Hagedorn et al., 1999;
Morrison et al., 1999; Sommer, 2001), suggesting an
interplay between cell extrinsic and intrinsic factors as a
mechanism regulating cell fate decisions. Sensory neuron
progenitors are apparently fate restricted as they emigrate
from the neural tube (Ma et al., 1999; Zirlinger et al.,
2002) or very soon thereafter. This early fate restriction is
the result of Wnt-activated h-catenin signaling (Hari et al.,
2002; Lee et al., 2004). Forced expression of h-catenin in
neural crest cells results in aberrant rostral migration,
aggregation, and differentiation into ectopic neurons
expressing the sensory neuron markers NeuroD, Brn-3a,
and neurogenin 2 (Ngn) (Lee et al., 2004). In an elegant
series of studies, Lee et al. (2004) present compelling
evidence demonstrating that neural crest cells exposed to
Wnt1 or cells constitutively expressing h-catenin differ-
entiate into sensory neurons at the expense of all other
neuronal phenotypes. These studies show signaling via the
canonical Wnt signaling pathway serves as an instructive
signal specifying neural crest cells as sensory neurons. A
very interesting question raised by this and other studies
is how are signals segregated so that all neural crest cells
exposed to Wnt1 and Wnt3a in the dorsal neural tube are
prevented from differentiating as sensory neurons.
Another way to look at this issue is to ask how intrinsic
heterogeneity is generated. For neural crest cells, hetero-
geneity could be determined stochastically or rather as a
consequence of local gradients of signaling molecules.
Either could provide a mechanism for coherent cohorts of
cells to differentially respond to local environmentally
derived instructive signals. This is a particularly interest-
ing issue because at the time that neural crest cells remainassociated on the dorsal neural tube they are exposed to
Wnt1, Wnt3, BMPs, and TGF-hs; which (BMP and TGF-
h) family member depends upon the species. Each of
these signaling molecules provides instructive cues for
fate restriction or specification to a particular phenotype
(Fig. 1). Responsiveness to any particular signaling
molecule present in the local environment might have
spatial and temporal constraints because all neural crest
cells exposed to Wnt1 in situ, for example, do not
differentiate as sensory neurons. The temporal effects on
cellular responsiveness are particularly evident for neural
crest cells giving rise to noradrenergic sympathetic
ganglion neurons.
Early studies implicated the neural tube and notochord
as sources of instructive factors required for the differ-
entiation of neural crest-derived cells into catecholaminer-
gic neurons in the trunk of avian embryos (Cohen, 1972;
Groves et al., 1995; Howard and Bronner-Fraser, 1985,
1986; Norr, 1973; Stern et al., 1991; Teillet and Le
Douarin, 1983). In embryos where the neural tube or
notochord was either removed or rotated through 908,
results suggested two sources of required factors for normal
localization and differentiation of catecholaminergic cells
(Groves et al., 1995; Stern et al., 1991; Teillet and Le
Douarin, 1983). These studies suggested that neural tube
and notochord provide some soluble signal(s) required for
both appropriate migration and differentiation as well as
implicating the dorsal aorta as the source of a signal
required for the differentiation of sympathetic ganglion
neurons. The neural tube-derived factor was tentatively
identified as a member of the TGF-h family of factors
(Howard and Gershon, 1993) while the dorsal aorta is the
source of BMPs (Reissmann et al., 1996; Shah et al., 1996).
Studies in vitro and in vivo establish BMP as a proximal
signal supporting expression of a transcription factor
cascade required for the differentiation of sympathetic
ganglion neurons as well as the acquisition of a noradre-
nergic phenotype (Fig. 1).BMPs are essential for sympathetic neuron development
BMPs were shown to be essential determinants of
neuronal differentiation by demonstrating an increase in
the number of neural crest-derived cells expressing tyrosine
hydroxylase (TH) or norepinephrine in cultures supple-
mented with BMP2, 4, or 7 (Reissmann et al., 1996; Shah et
al., 1996; Varley and Maxwell, 1996; Varley et al., 1995).
The capacity of BMP4 to support neurogenesis and selective
generation of autonomic and sensory progenitors has also
been demonstrated in embryonic stem cells (Mizuseki et al.,
2003). An in vivo requirement for BMP4 was nicely
demonstrated using gain-of-function approaches in avian
embryos by ectopically expressing BMP4 using retrovirus-
mediated gene transfer (Reissmann et al., 1996). In cells
ectopically expressing BMP4, the effectiveness of BMP4 in
Fig. 1. Analyses in vitro and in vivo have identified a series of growth factors and transcriptional regulators (markers) affecting different stages of neurogenesis
of neural crest-derived progenitor cells. This schematic diagram summarizes work from many laboratories and includes some information not explicitly
described in the body of the text; the complied data provides a roadmap for following important hallmark events in the development of autonomic, enteric, and
sensory neurons. Neural crest cells segregated from the neuroepithelium can be identified by the expression of FoxD3 and SOX10 (among other markers); cells
expressing FoxD3 give rise to neurons and not melanocytes (Kos et al., 2001). SOX10 maintains multipotency in neural crest-derived cells as well as
neurogenic potential (Kim et al., 2003). In the enteric nervous system, SOX10 and Pax3 together regulate RET (Lang and Epstein, 2003), which is required for
normal development of these neurons. Progenitor cells differentiate into sympathetic, parasympathetic, enteric, or sensory neurons in part dependent upon
instructive signals encountered early at or near the time of egress from the neural tube. Additionally, extrinsic cues encountered during migration or at sites
where neural crest-derived cells differentiate influence patterns of gene expression. In autonomic ganglia, expression of HAND2 appears to select cells as
noradrenergic sympathetic ganglion neurons as well as functioning in cell type-specific gene expression. In the sensory neuron lineage, the POU domain
transcription factor Brn3a, expressed downstream of Ngn, regulates a large array of genes influencing cell death, neurotransmitter expression, and axon
guidance (Eng et al., 2004). The signaling molecule sonic hedgehog (SHH) is necessary for the expression of neurogenin (Ungos et al., 2003). In the enteric
nervous system, HAND2 is expressed downstream of Phox2b (Christos Goridis, personal communication) in all segments of the developing gut (Wu and
Howard, 2002); the function of HAND2 in development of enteric neurons is unknown. The neurotrophin receptor TrkC is expressed early by neural crest-
derived cells whose potential is restricted to neuronal or glial lineages (Luo et al., 2003) as well as a subset of enteric neurons (Chalazonitis et al., 2001).
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evidenced by the expression of the noradrenergic marker
gene TH. The expression of BMP2, 4, and 7 in cells of the
dorsal aorta in mammals (Shah et al., 1996) and avians
(Reissmann et al., 1996) suggested an in vivo role of BMP
in the differentiation of sympathetic ganglion neurons. Since
null mutation of BMP4 is embryonic lethal prior to the
generation of peripheral neurons (Winnier et al., 1995;
Zhang and Bradley, 1996), a different strategy was needed
to assess the effects of loss of BMP function on generation
of sympathetic ganglion neurons, in situ. Loss-of-function
was achieved using the BMP4/7 antagonist Noggin (Smith
and Harland, 1992; Zimmerman et al., 1996) by the
implantation of Noggin-releasing beads at the dorsal aorta
(Schneider et al., 1999). Inhibition of BMPs at the site
where neural crest-derived cells differentiate into sympa-
thetic ganglion neurons resulted in the loss of noradrenergic
marker genes TH and dopamine-h-hydroxylase (DBH) as
well as the pan-neuronal markers neurofilament 160 and
SCG10. Similar studies demonstrate an essential role for
BMPs in the differentiation of parasympathetic ciliaryganglion neurons, with BMP5 and BMP7 as candidate
signals (Muller and Rohrer, 2002). In vitro, neural crest-
derived cells differentiate into noradrenergic neurons in
response to BMP2, 4, and 7 (Howard et al., 2000;
Reissmann et al., 1996; Varley and Maxwell, 1996; Varley
et al., 1995; Wu and Howard, 2001). This response is
mimicked by constitutive expression in neural crest-derived
cells of BMP type IA receptors (McPherson et al., 2000;
Varley et al., 1998) and most likely involves translocation of
SMAD1 to the nucleus (Wu and Howard, 2001). Taken
together, these studies implicate BMP2, 4, 5, and 7 as in
vivo instructive cues inducing differentiation of sympathetic
and parasympathetic ganglion neurons (Muller and Rohrer,
2002; Reissmann et al., 1996; Schneider et al., 1999).
However, which BMP family member is the essential factor
and whether BMPs provide the only instructive cue remains
unclear.
Once neural crest-derived cells have aggregated around
the dorsal aorta, the first marker of their specified
bautonomicQ fate is expression of CASH1 in avians
(Ernsberger et al., 1995; Groves et al., 1995) and MASH1
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vertebrate homologue of the Drosophila proneural genes
acheate-scute (Guillemot and Joyner, 1993; Jasoni et al.,
1994; Johnson et al., 1990). Transcripts encoding CASH1
are first detected in neural crest-derived cells in the region of
the dorsal aorta of chick embryos at Hamburger and
Hamilton’s (1951) stage 15 (Ernsberger et al., 1995; Groves
et al., 1995). Thus, CASHI is expressed prior to the time
that BMP can be detected in the dorsal aorta (Ernsberger et
al., 1995; Groves et al., 1995; McPherson et al., 2000) and
prior to the time that BMP Type I receptors are expressed in
precursors of sympathetic ganglion neurons (McPherson et
al., 2000). Additionally, in avian embryos when Noggin-
releasing beads are implanted around the dorsal aorta at a
time when migrating neural crest-derived cells localize
there, sympathetic ganglion neurons fail to differentiate and
CASH1 expression is only reduced but not extinguished
(Schneider et al., 1999). In rat neural crest-derived cells,
BMP2 supports the maintained expression of MASH1 (Lo
et al., 1997), suggesting that the role of BMP is to maintain
the expression of CASH1 (MASH1) rather than to induce its
expression (Lo et al., 1997; Schneider et al., 1999).
Alternatively, it is possible that in the primordia of the
sympathetic ganglia, BMP growth factors synthesized and
secreted by cells resident within the developing ganglion
function as a paracrine signal following initial induction by
aorta-derived BMP (McPherson et al., 2000). Regardless of
how this conundrum is resolved, these studies establish
BMP as an essential determinant of the noradrenergic
neuron phenotype.Intrinsic factors involved in the generation of peripheral
neurons
The requirement for BMP growth factors in the differ-
entiation of autonomic neurons is supported by both in vitro
and in vivo studies (Howard and Gershon, 1993; Muller and
Rohrer, 2002; Reissmann et al., 1996; Schneider et al.,
1999; Shah and Anderson, 1997; Shah et al., 1996; Varley et
al., 1995). The mechanism underlying BMP-induced differ-
entiation of autonomic neurons, although not completely
understood, is based on the coordinate expression of
transcription factors in neural progenitors once they localize
at the sites where they will ganglionate; for the primary
sympathetic chain, this is the dorsal aspect of the dorsal
aorta and a site along the oculomotor nerve in the retro-
orbital mesenchyme for parasympathetic ciliary ganglion
neurons (Fig. 1). Common to both sympathetic and para-
sympathetic neurons, this group of transcription factors
includes the homeodomain (HD) DNA binding proteins
Phox2b and Phox2a (Lo et al., 1999; Morin et al., 1997;
Pattyn et al., 1997, 1999; Stanke et al., 1999) and the bHLH
DNA binding protein CASH1 (MASH1) (Guillemot et al.,
1993; Hirsch et al., 1998; Lo et al., 1998). Additional
transcription factors induced in sympathetic ganglionprecursors are the bHLH DNA binding protein HAND2
(dHAND) (Howard et al., 1999, 2000) as well as the zinc
finger proteins GATA2 expressed in avian embryos (Groves
et al., 1995) and GATA3 expressed in mouse embryos (Lim
et al., 2000; Pandolfi et al., 1995). Examination of the
temporal expression profile of these DNA binding proteins
in neural crest-derived cells destined to differentiate as
noradrenergic neurons suggested a model of two parallel but
interacting pathways of gene regulation (Fig. 2). Further, the
compiled data suggested that specificity in the function of
these genes is based, in part, on their ability to cross-
regulate expression as well as act as co-transcriptional
regulators (see below).
In vertebrates, bHLH DNA binding proteins have several
functions including specification of neuronal progenitors,
neuronal fate, and differentiation (for review, see Bertrand et
al., 2002; Massari and Murre, 2000). However, as our
understanding of the function of this family of genes has
increased, it has become evident that for some of these
factors their function is determined by the cellular context in
which they are expressed. As a rule, homeodomain DNA
binding proteins function in specification of cell type-
specific identity. Interestingly, it has become a common
theme to find that bHLH and HD factors together function
in transcription factor cascades to regulate the steps required
for cell determination and differentiation (Bertrand et al.,
2002; Jan and Jan, 1993; Kintner, 2002; Lee, 1997; Lee and
Pfaff, 2003; Weintraub, 1993; Xu et al., 2003). In addition,
it has become increasingly evident that homeodomain and
zinc-finger DNA binding proteins function in concert to
modify or regulate the activity of bHLH factors. In the
context of developing sympathetic noradrenergic neurons,
results of gain-of-function or loss-of-function studies did not
always provide predicted outcomes, suggesting novel
functions/interactions for some of the transcriptional regu-
lators important for generation of this phenotype.
Our understanding of how neural precursors are selected
for the generation of neural crest-derived peripheral neurons
remains limited. For some lineages, notably sensory
neurons, proneural genes have been identified and their
function well studied (Bertrand et al., 2002; Ma et al., 1999;
Nakada et al., 2004; Quan et al., 2004; Scardigli et al., 2003;
Schuurmans et al., 2004). Identification of a proneural gene
that accounts completely for the selection of precursors of
autonomic neurons remains obscure. In the central nervous
system, MASH1 functions as a proneural gene (for review,
see Bertrand et al., 2002; Ross et al., 2003) as well as in
neuron subtype specification (Parras et al., 2001), but this
does not seem to be the case in peripheral neural crest-
derived neurons (Parras et al., 2001; Sommer et al., 1995);
in peripheral ganglia, MASH1 is required for expression of
pan-neuronal marker genes. In mice null for expression of
MASH1, all noradrenergic neurons, both central and
peripheral, are affected (Guillemot et al., 1993; Hirsch et
al., 1998; Lo et al., 1998). MASH1 expression is extin-
guished prior to or just after neural differentiation (Guille-
Fig. 2. Specification and differentiation of peripheral autonomic neurons are dependent upon the interplay between cell extrinsic and cell intrinsic factors. Initial
instructive cues from the neural tube influence neural crest cells that then respond to BMPs derived from the dorsa aorta or retro-orbital mesenchyme. Induction
of Phox2b and MASH1 is followed by the induction of HAND2 and Phox2a resulting in expression of pan-neuronal (SCG10, NF) and cell type-specific (TH,
DBH, ChAT, VAChT) genes. Since the recognized transcription factors required for the differentiation of noradrenergic sympathetic and cholinergic
parasympathetic neurons are the same, with the notable exception of HAND2. It is compelling to suggest that this diversity could be the result of exclusive
expression of HAND2 in precursors of noradrenergic sympathetic ganglion neurons. Cross-regulation of transcription factor expression suggests patterns of
regulation based on generation of local gradients.
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required for specification of neurotransmitter and other
aspects of a neuronal phenotype.
In vertebrates, the list of proneural genes is confined to
MASH1, Ngn, MATH1, and MATH5. In mice null for
expression of Ngn1 or Ngn2, as well as in zebrafish where
expression of Ngn1 is blocked, cranial sensory ganglia are
affected (Andermann et al., 2002; Fode et al., 1998; Ma et
al., 1998, 1999; Scardigli et al., 2001). However, in animals
carrying a double mutation for Ngn1 and Ngn2, in addition
to lacking cranial sensory ganglia, spinal sensory ganglia
and a subgroup of ventral spinal cord neurons are affected as
well (Fode et al., 1998; Gowan et al., 2001; Ma et al., 1998,
1999; Scardigli et al., 2001). Deletion of MASH1 results in
deficits in the generation of neural progenitors in the
olfactory sensory epithelium and in the ventral telencepha-
lon (Casarosa et al., 1999; Cau et al., 2002; Guillemot et al.,
1993; Horton et al., 1999; Ross et al., 2003), but not in the
sympathetic chain ganglia (Sommer et al., 1995). This
suggests that additional gene products with proneural
activity in the autonomic branch of the peripheral nervous
system remain to be identified (Hassan and Bellen, 2000).
The activity of HAND2 has some aspects of proneural
function. In vitro, ectopic expression of HAND2 increases
withdrawal of neural crest-derived cells from the cell cycle
and their subsequent differentiation into NE neurons
(Howard et al., 1999). Ectopic expression of HAND2, both
in vitro and in vivo, is sufficient for the expression of pan-
neuronal and NE-specific marker genes (Howard et al.,1999, 2000). HAND2 therefore couples neurogenesis with
cell-type-specific gene expression but is not expressed early
enough to classify it as a proneural gene. Additionally,
HAND2 has not been shown competent to induce differ-
entiation of NE neurons at the expense of other phenotypes.
Although a proneural gene for autonomic derivatives has
not yet been identified, the function of MASH1 is closely
linked to Phox2a and Phox2b, homeodomain DNA binding
proteins that regulate expression of the NE marker genes TH
and DBH (Brunet and Pattyn, 2002; Goridis and Brunet,
1999; Hirsch et al., 1998; Stanke et al., 2004; Swanson et
al., 1997, 1998; Zellmer et al., 1995; Yang et al., 1998); the
encoded proteins are the rate limiting and final (respec-
tively) biosynthetic enzymes required for NE synthesis (Fig.
2). Since the proper development of neural circuits requires
that neurons differentiate at the appropriate time, in the
correct place, and that they express characteristics specific
to their function and location, the function in the periphery
of MASH1 as a neuronal differentiation gene is quite
important and is likely required for maintaining the
expression of Phox2a (see below).Co-regulation of pan-neuronal and cell type-specific
genes
One aspect of specification of neuronal identity is the
coordinated expression of genes that regulate expression of
pan-neuronal (generic) properties with those that specify
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experimental evidence suggest that MASH1 might coor-
dinate expression of pan-neuronal and cell type-specific
genes via its influence on the expression of Phox2a (Hirsch
et al., 1998; Lo et al., 1998). This conclusion is based on
both gain-of-function and loss-of-function phenotypes
where both neurogenesis and expression of Phox2a are
affected. In rodents, BMP2 induces expression of MASH1
and Phox2a, but neither TH nor DBH: this suggests that
additional factors are required for the expression of NE
marker genes as well as implicating a non-overlapping
pathway in which HAND2 is expressed (Fig. 2). While
expression of Phox2a alone is not sufficient to support
expression of noradrenergic characteristics (Lo et al., 1998),
expression of Phox2a with co-activation of PKA supports
expression of TH but not neuronal differentiation in rodent
neural crest-derived cells (Lo et al., 1999). Under these
same conditions (expression of Phox2a and activated PKA),
the addition of BMP2 supports expression of TH and DBH
as well as differentiation into neurons (Lo et al., 1999).
Several lines of evidence suggest that HAND2 might link
the function of MASH1 and Phox2a with BMP, supporting
both neurogenesis and cell type-specific gene expression
(Howard et al., 2000; Xu et al., 2003). Ectopic expression of
HAND2, both in vitro (Howard et al., 1999) and in vivo
(Howard et al., 2000) is sufficient for expression of pan-
neuronal and NE cell type-specific genes as well as
generation of NE neurons. The most parsimonious model
suggests that MASH1 is required for the sustained
expression and regulation of Phox2a; the majority of data
describing the epistatic relationship of transcriptional
regulators thus far identified as required for specification/
differentiation of NE neurons combined with functional
consequences of gain-of-function or loss-of-function assays
indicates a complex of factors that can cross-regulate each
other’s expression (Fig. 2).
At the proximal level of the transcription network
required for noradrenergic differentiation are Phox2b and
MASH1. The Phox2 proteins are widely expressed in the
nervous system and are necessary for the specification/
differentiation of both central and peripheral neurons (for
review, see Brunet and Pattyn, 2002; Young et al., 2003).
In the periphery, loss-of-function studies demonstrate that
both enteric and autonomic neuron precursors depend
upon Phox2b for neuronal determination (for review, see
Brunet and Pattyn, 2002; Goridis and Rohrer, 2002;
Pattyn et al., 1997, 1999). In addition, Phox2b is an
essential regulator of the NE phenotype and possibly the
cholinergic phenotype (Morin et al., 1997; Muller and
Rohrer, 2002; Pattyn et al., 1999). Based on loss-of-
function studies, autonomic neurons do not develop in
mice lacking Phox2b and only marginally in animals null
for MASH1 (Guillemot et al., 1993; Hirsch et al., 1998;
Pattyn et al., 1999). However, the effect of loss-of-
function of MASH1 or Phox2b on subsequent expression
of pan-neuronal and cell type-specific genes suggests thattwo interacting but parallel pathways of transcriptional
regulation account for differentiation of sympathetic
noradrenergic neurons.
Expression of Phox2b and MASH1 initially occurs
independently, supporting the notion of two interdependent
cascades of transcriptional regulators required for the
differentiation of noradrenergic neurons (Fig. 2). It is
noteworthy that expressions of both Phox2b and MASH1
depend upon the HMG-box factor SOX10 (Kim et al.,
2003). Inasmuch as one function of SOX10 is to inhibit
overt neuronal differentiation, it is tempting to speculate that
neural crest cells that will differentiate into noradrenergic
neurons are maintained as progenitors until exposed to
BMP4 at the dorsal aorta. This would provide a mechanistic
basis for the findings that while ectopic expression of
MASH1 is not sufficient to induce differentiation of
noradrenergic neurons, ectopic expression of HAND2
induces Phox2a, TH, DBH, NF, and SCG10, and synthesis
of norepinephrine (Howard et al., 1999, 2000). While the
expression of Phox2a may be dependent upon both Phox2b
and MASH1, the expression of HAND2 appears independ-
ent of MASH1 (Howard, unpublished results) but dependent
upon Phox2b (Howard et al., 2000; Goridis, personal
communication). However, there must be an interaction
between gene products expressed downstream of Phox2b
and MASH1 because although noradrenergic neuron differ-
entiation is essentially lacking in MASH1 null mice,
Phox2b is expressed in precursor cells (Hirsch et al.,
1998; Lo et al., 1998). Support for the notion that there
are additional factors that link the function of Phox2b and
MASH1 is based on the finding that HAND2 is not
expressed in parasympathetic ciliary ganglion neurons
(Muller and Rohrer, 2002), although MASH1 and Phox2b
are essential for the differentiation of these parasympathetic
neurons. Based on the current available data, we favor a
model suggesting that HAND2 and Phox2a integrate
neurogenesis and cell type-specific gene expression in the
precursors of sympathetic ganglion neurons (Figs. 1 and 2).
This model would predict that in cholinergic and non-
autonomic noradrenergic neurons there are additional
factors that either inhibit the expression of HAND2 or
induce expression of additional transcriptional co-activators.
The idea that HAND2 might be inhibited in inappropriate
neurons or their precursors is supported by the finding that
ectopic expression of HAND2 in young (ED6) or older
(ED18) chick-dissociated dorsal root ganglia does not
induce expression of NE marker genes in either neurons
or support cells (Howard, unpublished observation). How-
ever, ectopic expression of HAND2 in precursors of
parasympathetic cholinergic ciliary ganglion neurons sup-
ports sustained expression of NE marker genes (Muller and
Rohrer, 2002). Interestingly, ectopic expression of BMP in
the precursors of ciliary ganglion neurons induces expres-
sion of Phox2b but not HAND2, and the resulting neurons
are cholinergic (Muller and Rohrer, 2002). One conclusion
that can be drawn from these data is that expression of
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noradrenergic. With the exception of HAND2, all of the
transcriptional regulatory genes identified as important for
the generation of NE neurons are also required for the
development of cranial parasympathetic ganglia (Fig. 1).
Both MASH1 and Phox2 are necessary determinants of
cranial parasympathetic ganglia (Hirsch et al., 1998; Morin
et al., 1997; Pattyn et al., 1999). The fact that in the
environment of the ciliary ganglion, BMP does not induce
HAND2 or the differentiation of NE neurons implies early
segregation of sympathetic and parasympathetic neuronal
precursors (White and Anderson, 2001). Although not
completely understood at this time, these data suggest not
only the presence of additional transcriptional regulators
controlling NE differentiation but also functions for
HAND2 independent of specification or differentiation of
NE neurons.
Additional transcriptional regulators shown to have a
functional role in specification and differentiation of
autonomic and serotonergic neurons are GATA-2 and
GATA-3 (Groves et al., 1995; Patient and McGhee, 2002).
The GATA family of zinc-finger DNA binding proteins has
six members, some of which function in cell fate specifi-
cation or cell type-specific gene expression (Karumaratne et
al., 2002; Patient and McGhee, 2002; Zhou et al., 2000).
GATA-4 and GATA-6 are highly expressed in neural crest,
embryonic ectoderm, and neural tube (Nemer and Nemer,
2003), and are both upstream regulators of BMP4 (Nemer
and Nemer, 2003). In very compelling studies employing
avian embryos, the expression of GATA-2 has been
demonstrated to be dependent upon BMP4 and induced
by both Phox2b and HAND2 (Tsarovina et al., 2004; H.
Rohrer, personal communication). Using ectopic expression
of a dominant-negative form of GATA-2 in chick, a
significant reduction in expression of TH as well as reduced
neurogenesis implicates GATA-2 as an important transcrip-
tional regulator in the differentiation of noradrenergic
sympathetic ganglion neurons. In mouse embryos, GATA-
2 functions in the specification of subgroups of serotonergic
neurons but is also expressed downstream of homeodomain
DNA binding proteins, implying an unusual epistatic
relationship between GATA-2 and bHLH DNA binding
proteins and HD proteins required for specification and
differentiation of noradrenergic and serotonergic neurons.
Because GATA-2 specifies cell fate in a subclass of rostral
serotonergic neurons but downstream of required homeo-
domain DNA binding proteins (Craven et al., 2003), this
raises the question of the function of GATA-2 in the
specification or differentiation of noradrenergic sympathetic
ganglion neurons. GATA-2 is expressed in precursors to
sympathetic ganglion neurons (Groves et al., 1995) and has
a functional role in both neurogenesis (Tsarovina et al.,
2004) and expression of norepinephrine (Groves et al.,
1995). The epistatic relationship of GATA-2 to other
transcriptional regulators required for expression of TH
and DBH in precursors of sympathetic NE neurons suggeststhe possible involvement of GATA-2 in the regulation of
neurotransmitter biosynthesis. This idea is supported by the
phenotype of animals carrying a null mutation of GATA-3.
The phenotypes and defects described in animals carrying
targeted mutation of GATA-3 suggest that HAND2 is one
affected transcriptional regulator. In these animals, although
Phox2 genes are expressed, expression of neither TH nor
DBH is detectable. These animals appear to die due to lack
of norepinephrine in sympathetic neurons (Lim et al., 2000).
Our data implicate HAND2 as the critical component
regulating expression and function of DBH in noradrenergic
autonomic neurons (Howard et al., 2000; Xu et al., 2003).
The link between GATA factors and HAND2 is functional.
GATA family members are co-transcriptional regulators of
cell-type-specific genes with HAND2 in the heart (Dai et al.,
2002; McFadden et al., 2000) as well as in regulating
transcription of DBH transiently expressed in P19 cells
(Howard, unpublished observation). These results suggest
GATA-2, in avian embryos, as a co-transcriptional activator
with HAND2 and Phox2a of DBH.
How specification of cell-type-specific characteristics
occurs in relation to the control of neuronal differentiation
remains unclear. A necessary step in generating specific
neuronal phenotypes from previously specified progenitors
requires expression of genes encoding cell fate determinants.
In the neural tube, organizing centers in the dorsal and ventral
domain are well established. It is possible that neural crest
cells receive some signals prior to their egress from the neural
tube or that soluble factors provide signals to cells as they
migrate. In whatever manner this signaling occurs, it is
evident that bHLH transcription factors regulating general
aspects of neuronal specification also regulate cell type-
specific gene expression.We have presented evidence linking
the function(s) of HAND2 with Phox2 proteins and BMP4 in
the development of sympathetic (Howard et al., 2000; Xu et
al., 2003) and enteric neurons (Howard, unpublished data; C.
Goridis, personal communication; Wu and Howard, 2002).
One aspect of the differentiated neuronal phenotype that is
accessible to experimental manipulation and assessment is
the coordinated expression of pan-neuronal and cell type-
specific phenotypic characteristics. Although the mecha-
nisms governing these interactions have not been well
established for the majority of neurons, inroads have been
made in our understanding of cell type-specific gene
expression in noradrenergic sympathetic ganglion neurons.
We suggest that HAND2 is a pivotal player in the differ-
entiation of neural crest-derived noradrenergic sympathetic
ganglion neurons linking expression of pan-neuronal genes
(SCG10, NF) with the noradrenergic marker genes TH and
DBH. In the nervous system, the expression of transcripts
encoding HAND2 is restricted to sympathetic noradrenergic
and enteric neurons (Howard et al., 1999; Wu and Howard,
2002). This pattern of expression sets HAND2 apart from
other transcription factors required for the differentiation of
noradrenergic neurons, such as Phox2a, Phox2b, and
MASH1, which are also expressed in a diverse array of
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tional regulators identified as important in the determination
of neurotransmitter phenotype appear to function exclusively
in this role; specifications of other aspects of neural identity
are linked to neurotransmitter determination (reviewed in
Bertrand et al., 2002; Brunet and Ghysen, 1999; Goridis and
Brunet, 1999). A review of our current knowledge suggests
that proposing a simple hierarchical model of transcription
factor function will not account for all available data on NE
neuron development. In parasympathetic neurons, such as
found in the ciliary ganglion, MASH1, Phox2b, and Phox2a
do not induce the expression of HAND2 and noradrenergic
phenotypic characteristics are only transiently expressed
(Muller and Rohrer, 2002), suggesting that one function of
HAND2 is to maintain the expression of noradrenergic
characteristics in the appropriate neurons. Clearly, the
different transcriptional regulators controlling specification
and differentiation of sympathetic noradrenergic neurons
have distinct functions within the various neuronal popula-
tions in which they are expressed.Transcriptional regulation of neurotransmitter
biosynthesis
Although only a few cis-acting regulatory elements that
control expression of neuron subtype-specific genes have
been identified, it is becoming evident that interactions
between homeodomain and bHLH DNA binding proteins
are key mechanisms coordinating expression and function
of target genes (Dubreill et al., 2002; Lee and Pfaff, 2003;
Mizuguchi et al., 2001; Novitch et al., 2001; Scardigli et al.,
2001). We have expanded our understanding of one
regulatory circuit involved in the determination of neuronal
identity by demonstrating an interaction between HAND2
and Phox2a in transcriptional control of DBH (Xu et al.,
2003). Using transient transfection in P19 and NT-2 cells,
we have shown that HAND2 synergistically enhances
Phox2a-driven transcriptional activity at the DBH promoter
(Fig. 3). Transactivation of DBH by either Phox2a or
Phox2a plus HAND2 is enhanced by elevating cAMP (Kim
et al., 1994, 1998; Swanson et al., 1997, 1998, 2000; Xu et
al., 2003). This was an intriguing result because of potential
interaction with signaling cascades downstream of cAMP,
BMP, and retinoic acid (RA), and involving MAPK path-
ways required early for the differentiation of noradrenergic
neurons (Bilodeau et al., 2000; Dupin and Le Douarin,
1995; Holzschuh et al., 2003; Howard et al., 2000; Maxwell
and Forbes, 1990; Rockwood and Maxwell, 1996; Wu and
Howard, 2001).
That the BMP-induced generation of noradrenergic
sympathetic ganglion neurons also involves signaling
downstream of cAMP was inferred from studies showing
that Phox2a induces the expression of TH in collaboration
with cAMP downstream of BMP2 (Lo et al., 1999; Swanson
et al., 1997). Additional sites of action of cAMP in thegeneration of NE neurons can be inferred from results
demonstrating that elevated cAMP results in a loss of
noradrenergic cells from neural crest-derived precursors in
vitro (Bilodeau et al., 2000; Maxwell and Forbes, 1990).
This result suggested that cAMP-responsive elements might
regulate some of the genes required for expression of
noradrenergic phenotypic characteristics. This is true for TH
where at least three transcription factors, CREB, ATF1/2,
and CREM, have been shown to regulate basal (CRE/AP-1)
and induced (CRE/AP-2) transcriptional activity in a variety
of cells (Ghee et al., 1998; Kim et al., 1993; Lazaroff et al.,
1995; Lewis-Tuffin et al., 2004; Nagamoto-Combs et al.,
1997; Suzuki et al., 2002); CREB appears to be one site of
convergence for extrinsic factor signaling (reviewed in
Lewis-Tuffin et al., 2004; Lonze and Ginty, 2002) regard-
less of the proximal effector (Fig. 3). In zebrafish, if Ap2a
expression is knocked down, the number of cells expressing
TH near the dorsal aorta is significantly reduced, suggesting
an essential function in the regulation of noradrenergic
marker genes (O’Biren et al., 2004). Recent evidence
suggests that in a manner similar to what occurs at the
DBH promoter (see below), additional cell or tissue-specific
co-activators influence TH transcriptional regulation
(Lewis-Tuffin, 2004; Quinn, 2002). Detailed investigation
of TH regulation in neural crest-derived autonomic neurons
at early stages of development will likely identify these cell
type-specific co-activators.
Agents that increase cAMP are present in 10-day chick
embryo extract (CEE) and are required to support the
expression of noradrenergic phenotypic characteristics in
vitro. Under these conditions, transcripts encoding HAND2
and Phox2a are expressed, and norepinephrine is synthe-
sized and stored. Elevating PKA by the addition of the
membrane permeable analogue of cAMP, 8-Bromo-cAMP,
results in a significant decrease in transcripts encoding
HAND2 and Phox2a as well as a loss in NE neurons. This
result suggested that PKA and cAMP may be important in
intracellular signaling in the context of NE differentiation
but that PKA might not be signaling downstream of cAMP
(Liu and Howard, unpublished observation). PKA has been
implicated in growth factor signaling in a variety of tissues
including the kidney (Gupta et al., 1999), the central
nervous system (Epstein et al., 1996; Hammerschmidt et
al., 1996), and the limb (Lee and Chuong, 1997). BMP can
activate PKA, independent of cAMP, and phosphorylate
CREB independent of SMAD proteins (Gupta et al., 1999;
Lee and Chuong, 1997). The possibility that cAMP and
PKA may have differential effects on the noradrenergic
differentiation of neural crest-derived cells is supported by
earlier findings showing that elevation of PKA is inhibitory
for expression of norepinephrine (Bilodeau et al., 2000;
Maxwell and Forbes, 1990) but that increased cAMP
resulted in enhanced expression of TH and differentiation
of noradrenergic neurons (Dupin et al., 1993). The apparent
conflicts in these results most likely reflect differences in the
treatment and growth conditions used in the various studies
Fig. 3. (A) HAND2 regulates cell type-specific expression of NE in concert with Phox2a by a novel mechanism for bHLH DNA binding proteins. Domain
mapping studies have demonstrated that HAND2 interacts in a scaffold of proteins and does not appear to directly bind DNA. Signaling downstream of both
BMP4 and cAMP/PKA influences expression and function of HAND2 and Phox2a. (B) The functional activity of HAND2 at the DBH promoter resides in the
bHLH domain (Fig. 4) and requires the CRE/AP1 site in the DB1 enhancer. Phox2a binds at three homeodomain (HD) binding sites for maximal activity. There
are three putative HAND2 binding sites (E-box) in the proximal DBH promoter. HAND2 serves a dual role, influencing both neurogenesis, downstream of
BMP4, and NE biosynthesis in a cAMP-dependent manner. The schematic of the Phox2a proximal promoter is adopted from Swanson et al. (2000) and based
in part on sequence data (Hong et al., 2001).
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signaling downstream of cAMP and PKA. The biphasic
response to cAMP, depending upon the presence in the
growth medium of factors that activate cAMP, suggested
more than one site of action of cAMP. This divergence in
signaling via cAMP or PKA independent of cAMP is
supported by our finding that agents that block PKA but not
cAMP inhibit the increased differentiation of noradrenergic
cells by BMP4 (Liu and Howard, in preparation). Con-
verging lines of evidence thus suggest complicated inter-
actions in growth factor-mediated signaling in not only the
generation of neural crest-derived noradrenergic neurons but
also in the biosynthesis of neurotransmitter as well (Howardand Gershon, 1993; Howard et al., 2000; Reissmann et al.,
1996; Schneider et al., 1999; Wu and Howard, 2001; Xu et
al., 2003).
Attention was focused on possible interaction with
transcriptional co-activators downstream of cAMP and
PKA because of functional consequences on transcriptional
regulation of DBH by Phox2a in response to activation of
these signaling pathways. In intriguing studies, it was shown
that while expression of TH by neural crest-derived cells is
supported by Phox2a in the presence of cAMP, DBH is not
expressed (Lo et al., 1999). This differential expression
pattern of TH and DBH might be explained by results
demonstrating that at the TH promoter, Phox2a and PKA act
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PKA act synergistically to transactivate DBH. The differ-
ential effects of cAMP and PKA are likely based on the fact
that, other than basal activity, transactivation of DBH by
Phox2a requires that Phox2a be dephosphorylated (Adachi
and Lewis, 2002). This dephosphorylation occurs in
response to PKA-mediated events and enhances the DNA-
binding ability of Phox2a. Interestingly, HAND2 is phos-
phorylated in helix1 (dimerization domain) at threonine 112
and serine 114 in a PKA-dependent manner (Fig. 4), and
this phosphorylation is required for proper dimerization and
function in both limb morphogenesis (Firulli et al., 2003) as
well as at the DBH promoter (Liu and Howard, in
preparation). Detailed analysis of the interactions of
HAND2 and Phox2a at the DBH promoter (Fig. 3B)
demonstrated that while mutation of the Phox2a homeo-
domain binding sites, HD1, HD2, and HD3, results in the
loss of HAND2/Phox2a transactivation of DBH, it is the
interaction of HAND2 at the CRE/AP1-HD1/2 domains in
the DBH enhancer that is required for synergistic activation
by HAND2 (Rychlik et al., 2003; Shaskus et al., 1992; Xu et
al., 2003). HAND2 functions as a transcriptional activator
without directly binding to E-box sequences in the DB1
enhancer of the DBH promoter, suggesting that HAND2-
mediated DBH transcriptional activity occurs by protein–
protein interactions with other transcriptional regulatorsFig. 4. Schematic drawings of the protein structure of HAND2 (Howard,
unpublished data), Phox2a (Hong et al., 2001), and CBP (Harrod et al.,
2000; Swenson et al., 2001) show sites identified as functionally important
for the interaction of HAND2 and Phox2a at the DBH promoter. In
HAND2, activity at the DBH promoter requires the HLH (cyan)
dimerization domain but not the basic (royal blue) DNA binding domain.
Phosphorylation by PKA of threonine (T) 112 and serine (S) 114 (orange
bars) is required for dimerization as well as synergistic activation of DBH
with Phox2a. Three homeodomain (HD) binding sites (red bars) must be
occupied by Phox2a for maximal transactivation of DBH but are not
sufficient for HAND2 synergistic activation (Rychlik et al., 2003; Xu et al.,
2003). In CBP, HAND2, Phox2a, and E1A bind at the C/H3 domain (HAT,
histone acetyltransferase domain).(Fig. 3A). Although we were unable to demonstrate physical
contact between HAND2 and Phox2a in IP/Western blot
assays, such interaction has been reported (Rychlik et al.,
2003); differences in experimental approach most likely
account for this discrepancy, but additional studies will be
needed to resolve this issue. HAND2 synergistic activation
of DBH is blocked by E1A (CBP/P300 inhibitory protein;
Arany et al., 1995), suggesting that HAND2 interacts with
cAMP response element binding protein (CBP) in this
transcriptional complex. Both HAND2 and Phox2a have
been shown to physically interact with CBP/P300 (Fig. 4);
Phox2a and HAND2 interact with CBP at the CH3 domain
(Dai et al., 2002; Swanson et al., 2000). In HAND2,
interaction with the CH3 domain occurs via its bHLH
domain (Dai et al., 2002). Our data suggest that HAND2
interacts in a scaffold of proteins as one of several
transcriptional regulators of DBH and that part of this
functionality resides in the bHLH domain. In addition to a
functional role in regulating activity of DBH in a DNA
binding-independent manner, we have evidence suggesting
that posttranslational modification in helix 1 of HAND
proteins is a novel mechanism regulating choice of
dimerization partner (Firulli et al., 2003).
In the presence of the putative HAND2 dimerization
partner E12, synergistic activation of DBH transcription is
titrated away, suggesting that HAND2 does not functionally
dimerize with E12 in the DBH transcription complex. We
have demonstrated that HAND2 forms homodimers and that
the strength of dimerization is determined, in part, by
posttranslational modification of threonine 112 or serine 114
in helix1 of HAND2 (Anthony Firulli, personal communi-
cation; Firulli et al., 2003). Analysis of HAND2 activity in
the regulation of cardiac-specific genes, limb morpho-
genesis, and neurotransmitter biosynthesis suggests that
the diversity of HAND2-mediated responses is due in part to
the ability of HAND2 to function under some circumstances
independent of DNA binding, to functionally dimerize to a
large array of partners, and to show cooperative interactions
in scaffolds of transcription factors and co-activators
including CBP/P300, GATA4, and Nkx2.5 (Dai et al.,
2002; Firulli et al., 2003; McFadden et al., 2002; Thatta-
liyath et al., 2002; Xu et al., 2003).Expression of cholinergic marker genes
In addition to parasympathetic ganglion neurons that are
primarily cholinergic, a subset of sympathetic ganglion
neurons is cholinergic as well. For some of these neurons,
especially those innervating the rodent footpad or perios-
teum, expression of the cholinergic marker genes choline
acetyltransferase (ChAT) and the vesicular acetylcholine
transporter (VAChT) occurs in response to target-derived
factors (for review, see Asmus et al., 2001; Ernsberger and
Rohrer, 1999; Francis and Landis, 1999); the inducing factor
has been tentatively identified as cardiotrophin-1 (James
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upregulation of cholinergic marker genes is reduced expres-
sion of the noradrenergic marker genes TH, DBH, and
Phox2a (Cervini et al., 1994; Dziennis and Habecker, 2003,
2004; Rao and Landis, 1993). Although the molecular
mechanisms underlying this regulation are not well under-
stood, some aspects of cholinergic differentiation have been
extensively studied. Expression of ChAT and VAChT is
indicative of cholinergic differentiation regardless of
whether their expression is dependent upon target-derived
factors or occurs independently earlier in development. The
genes encoding these proteins comprise a cholinergic gene
locus and their expression is coordinately regulated (for
review, see Berrard et al., 1995; Berse and Blusztajn, 1995;
Shimojo and Hersh, 2004). Expression of this pair of
cholinergic marker genes is regulated in a PKA-dependent
manner (Inoue et al., 1995; Lonnerberg et al., 1995; Misawa
et al., 1995; Shimojo et al., 1998), although many of the
growth factors (e.g., CNTF, LIF) shown to influence
expression of ChAT or VAChT are not known to signal via
PKA (Gould and Butcher, 1989; Hersh and Shimojo, 2003;
Kamegai et al., 1990; Knusel et al., 1991). Expression of
ChAT/VAChT is regulated by a complex comprised, in part,
by a silencer element (NRSE) and an enhancer element
(Lonnerberg et al., 1995; Maue et al., 1990; Shimojo and
Hersh, 2004). Activity at the NRSE is regulated by the
transcription factor RE-1 silencing transcription factor
(REST) (Chong et al., 1995); REST is also known as
neuron-restricted silencing factor (NRSF) (Schoenherr and
Anderson, 1995). This element is a silencer and represses
expression of neuronal genes in non-neuronal cells (Chong et
al., 1995; Mieda et al., 1997) as well as regulating neuron-
specific gene expression in neurons (to reference Kallunki et
al., 1997; Palm et al., 1998; Timmusk et al., 1999). There is
evidence that REST or truncated forms of REST (e.g.,
REST4) can also function as enhancers of some neuronal
genes. This has been demonstrated for VIP, which is co-
expressed in most neural crest-derived peripheral cholinergic
neurons (Hamelink et al., 2004). Interestingly, putative RE-1
regulatory domains have been reported as present in genes
encoding TH, DBH, ChAT, VIP, and VAChT (Afar et al.,
1996; Hahm et al., 1997; Hamelink et al., 2004; Ishiguro et
al., 1993, 1995; Lonnerberg et al., 1995; Schoenherr et al.,
1996). Clearly, cell type-specific regulation of cholinergic
(and noradrenergic) marker genes is quite complex and likely
involves additional cis-regulatory elements yet to be
identified.Concluding remarks
The specification and differentiation of peripheral
neural crest-derived neurons depend, in a large part, on
the gene regulatory activities of members of the bHLH
and homeodomain families of DNA binding proteins.
Exactly how integration of extrinsic and intrinsic signal-ing is parlayed into differentiation and cell type-specific
gene expression in different classes of neurons remains a
focus of intense interest. The hierarchical nature of
transcriptional regulation and the demonstrated effects of
MASH1, HAND2, and Phox2 proteins in differentiation
of subsets of peripheral neural crest-derived neurons lead
one to speculate that the repertoire of functional
consequences downstream of transcriptional regulatory
protein activation will involve domains of functionality
not yet identified. Several lines of evidence indicate that
multiple functional domains in an individual DNA bind-
ing protein may serve as a mechanism to expand their
capacity to regulate genes in more than one manner. We
speculate that in addition to the identification of new cis-
regulatory mechanisms and new transactivating factors, in
the future, studies will focus on expanding our under-
standing of how modifications in chromatin structure
function in determining which genes are transcribed and
which genes are silenced.Acknowledgments
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